Also worthy of note in a discussion of arteriogenic ED is propionyl-L-carnitine (PLC)
When you combine that with appetite suppression from GLP-1 and the insulin-sensitising effects of GIP, you get a compounding effect that the dual agonists do not fully replicate
Type 2 diabetes is common in patients with obesity, and obesity increases production of estrogen hormones to abnormal levels, causing further fluctuation in periods and ovulation along with an increased risk of pregnancy complications and miscarriage
Regarding humans, there is not much clinical evidence yet, but there are many anecdotal reports from people who take Ozempic for weight loss or diabetes
Individual results vary based on age, health status, lifestyle factors, and treatment adherence
If you arent sure if weight loss injections are right for you, hormone replacement therapy could be an alternative treatment to help you lose weight